pandemic news, it pours. On a Monday that brought unexpectedly positive vaccine news from Pfizer Inc. and BioNTech SE, the Food and Drug Administration also granted emergency use authorization to an Eli Lilly & Co.
drug to treatment for individuals newly infected with the coronavirus. It's the first to be approved of a promising group of therapies called monoclonal antibodies that mimic the body’s response to infection, and could be a powerful weapon in the pandemic fight.
Some questions remain about Lilly's treatment, called bamlanivimab, which was found to reduce the viral load in patients and may help keep people out of the hospital.